CXCR4 Is a Novel Target of Cancer Chemopreventative Isothiocyanates in Prostate Cancer Cells

Isothiocyanates (ITCs) derived from cruciferous vegetables, including phenethyl isothiocyanate (PEITC) and sulforaphane (SFN), exhibit in vivo activity against prostate cancer in a xenograft and transgenic mouse model, and thus are appealing for chemoprevention of this disease. Watercress constituent PEITC and SFN-rich broccoli sprout extract are under clinical investigations but the molecular mechanisms underlying their cancer chemopreventive effects are not fully understood. The present study demonstrates that chemokine receptor CXCR4 is a novel target of ITCs in prostate cancer cells. Exposure of prostate cancer cells (LNCaP, 22Rv1, C4-2, and PC-3) to pharmacologically applicable concentrations of PEITC, benzyl isothiocyanate (BITC), and SFN (2.5 and 5 μmol/L) resulted in downregulation of CXCR4 expression. None of the ITCs affected secretion of CXCR4 ligand (stromal-derived factor-1). In vivo inhibition of PC-3 xenograft growth upon PEITC treatment was associated with a significant decrease in CXCR4 protein level. A similar trend was discernible in the tumors from SFN-treated TRAMP mice compared with those of control mice, but the difference was not significant. Stable overexpression of CXCR4 in PC-3 cells conferred significant protection against wound healing, cell migration, and cell viability inhibition by ITCs. Inhibition of cell migration resulting from PEITC and BITC exposure was significantly augmented by RNAi of CXCR4. This study demonstrates, for the first time, that cancer chemopreventive ITCs suppress CXCR4 expression in prostate cancer cells in vitro as well as in vivo. These results suggest that CXCR4 downregulation may be an important pharmacodynamic biomarker of cancer chemopreventative ITCs in prostate adenocarcinoma. Cancer Prev Res; 8(5); 365–74. ©2015 AACR.

[1]  References , 1971 .

[2]  L. Wattenberg.  Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. , 1977, Journal of the National Cancer Institute.

[3]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[4]  B. Ketterer.  Dietary isothiocyanates as confounding factors in the molecular epidemiology of colon cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  S. Hecht,et al.  Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. , 1999, The Journal of nutrition.

[6]  R. Goldbohm,et al.  Brassica vegetables and cancer prevention. Epidemiology and mechanisms. , 1999, Advances in experimental medicine and biology.

[7]  A. Whittemore,et al.  Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  J. Stanford,et al.  Fruit and vegetable intakes and prostate cancer risk. , 2000, Journal of the National Cancer Institute.

[9]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[10]  S. Saccani,et al.  Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.

[11]  S. Srivastava,et al.  Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. , 2003, Carcinogenesis.

[12]  K. Pienta,et al.  Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo , 2003, Journal of cellular biochemistry.

[13]  R. Dhir,et al.  Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. , 2003, Carcinogenesis.

[14]  E. Galun,et al.  Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  H. Klocker,et al.  The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. , 2004, Journal of experimental therapeutics & oncology.

[16]  Shivendra V. Singh,et al.  Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2 , 2004, Oncogene.

[17]  J. Nelson,et al.  Caspase-Dependent Apoptosis Induction by Phenethyl Isothiocyanate, a Cruciferous Vegetable-Derived Cancer Chemopreventive Agent, Is Mediated by Bak and Bax , 2005, Clinical Cancer Research.

[18]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  A. Kong,et al.  Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells , 2005, Oncogene.

[20]  P. Maroni,et al.  HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB , 2006 .

[21]  Xiyun Deng,et al.  CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12 , 2006, The Prostate.

[22]  Shivendra V. Singh,et al.  Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. , 2006, Cancer research.

[23]  R. Dhir,et al.  Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. , 2006, Carcinogenesis.

[24]  J. Chiao,et al.  Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. , 2006, Carcinogenesis.

[25]  K. Tsuneyama,et al.  Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer , 2008, Cancer science.

[26]  M. Cher,et al.  CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone , 2008, Molecular Cancer Research.

[27]  Alfred L. Fisher,et al.  Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. , 2009, Cancer research.

[28]  S. Amin,et al.  Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. , 2009, Cancer research.

[29]  Ki Han Kwon,et al.  Pharmacokinetics and Pharmacodynamics of Broccoli Sprouts on the Suppression of Prostate Cancer in Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mice: Implication of Induction of Nrf2, HO-1 and Apoptosis and the Suppression of Akt-dependent Kinase Pathway , 2009, Pharmaceutical Research.

[30]  Shivendra V. Singh,et al.  d,l-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells , 2009, Molecular Cancer Therapeutics.

[31]  H. Nagai,et al.  Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells , 2009, Molecular Cancer.

[32]  D. Ravichandran,et al.  Adjuvant therapy decisions in breast cancer: comparison of a multi disciplinary team's decisions with the recommendations of web-based computer programme “Adjuvant Online”. , 2009 .

[33]  Woojin Jun,et al.  HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells , 2010, Cellular and Molecular Life Sciences.

[34]  Shivendra V. Singh,et al.  Sulforaphane Inhibits Constitutive and Interleukin-6–Induced Activation of Signal Transducer and Activator of Transcription 3 in Prostate Cancer Cells , 2010, Cancer Prevention Research.

[35]  S. Sheng,et al.  Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells. , 2010, Translational oncology.

[36]  M. Uhlén,et al.  CXCR4 and cancer , 2010, Pathology international.

[37]  Shivendra V. Singh,et al.  Phenethyl Isothiocyanate Sensitizes Androgen-Independent Human Prostate Cancer Cells to Docetaxel-Induced Apoptosis In Vitro and In Vivo , 2010, Pharmaceutical Research.

[38]  J. Nelson,et al.  Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. , 2011, Journal of the National Cancer Institute.

[39]  Wenshu Wu,et al.  SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis , 2011, Molecular Cancer.

[40]  M. Dunn,et al.  Prostate cancer overview. , 2011, Seminars in oncology nursing.

[41]  Shivendra V. Singh,et al.  Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research. , 2012, Carcinogenesis.

[42]  Y. S. Kim,et al.  Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment , 2012, International journal of oncology.

[43]  B. Turner,et al.  Prostate cancer overview. Part 1: non-metastatic disease. , 2012, British journal of nursing.

[44]  L. Garraway,et al.  The genomic landscape of prostate cancer , 2012, Front. Endocrin..

[45]  Liping Xie,et al.  Cruciferous vegetables intake and risk of prostate cancer: A meta‐analysis , 2012, International journal of urology : official journal of the Japanese Urological Association.

[46]  M. Cher,et al.  PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling , 2013, Molecular Cancer.

[47]  Simon C Watkins,et al.  Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy. , 2013, Cancer research.

[48]  M. Roobol,et al.  Risk stratification in prostate cancer screening , 2013, Nature Reviews Urology.

[49]  W. Sakr,et al.  Transcriptional Regulation of CXCR4 in Prostate Cancer: Significance of TMPRSS2-ERG Fusions , 2013, Molecular Cancer Research.

[50]  Shivendra V. Singh,et al.  Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells. , 2013, Carcinogenesis.

[51]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[52]  Xiang Li,et al.  MicroRNA‐494‐3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer , 2014, The Prostate.

[53]  I. Herr,et al.  Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells , 2014, International journal of oncology.

[54]  Ping Yang,et al.  Potential mechanisms of benzyl isothiocyanate suppression of invasion and angiogenesis by the U87MG human glioma cell line. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[55]  Yi Cai,et al.  TMPRSS2/ERG Fusions , 2015 .